跳至主要内容
临床试验/JPRN-UMIN000003459
JPRN-UMIN000003459已完成未知

Combination therapy with azelnidipine or trichlormethiazide added on olmesartan in hypertensive patients with glucose intolerance - Combination therapy with azelnidipine or trichlormethiazide added on olmesartan in hypertensive patients with glucose intolerance

Kanazawa Medical University Diabetes & Endocrinology0 个研究点目标入组 40 人开始时间: 2010年4月7日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1)Among patients on azelnidipine or trichlormethiazide 2)Severe hepatic disease 3)Severe renal disease(During dialysis) 4)pregnancy or possibility of the pregnancy 5)posses hypersensitivity to azelnidipine or trichlormethiazide 6)Patients with insulin treatment or scheduling the insulin administration 7)FBS 100mg/dl moreover HbA1c 5.2 moreover 8)Patients who are inadequate to entry this study by physians in charge

研究者

发起方
Kanazawa Medical University Diabetes & Endocrinology

相似试验